Who We Are
Constellation Life Sciences is a China-based MedTech company focused on bringing best-in-class therapeutic and diagnostic MedTech products, services, and unique technologies targeting preventive care, chronic diseases and patient monitoring to China and around Asia.

We are not an agent or a rep, we invest in our partners, take ownership, and orchestrate their China entry and commercialization.

Our team will then leverage our on-the-ground resources and partners to drive registration, managing clinical trials, market access, commercialization to logistics to launch the product in China.
The Constellation Life Sciences Funnel
China’s MedTech market is extremely fragmented with 185,000 MedTech distributors across the country. Access to the right channels and distribution is the key to supporting any go-to-market strategy. Navigating this network is a daunting task for any company.
The top 20 MedTech manufacturers has 14% of the market
The CLS Commercial Partners Network
Constellation Life Sciences has commercial partnerships with China’s largest healthcare companies, including the largest two national distributors: Sinopharm and Shanghai Pharma. In addition, CLS has established strategic relationships with many regional distributors such as the Shandong Wego Group, one of two Chinese companies in the global MedTech 100. As an example of the Group’s reach, Shandong Wego has a commercial network with a 4,000-person sales team with direct accounts at 7,000 hospitals. Finally, CLS works with multiple large in-country foreign multinationals which cover a wide spectrum of hospitals, academia research facilities and third-party laboratories.
Network Highlights